Biocellgraft Delivers The World's First Injectable Oral Tissue Advancing Therapy To Treat Unmet Gum And Bone Concerns
ORAFYL. Oral Health is Overall Health Demand for OraFyl Prompts BioCellgraft and Celularity to Expedite their Strategic Planning Process fo ...
Fierce Pharma3h
FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...
Becker's Spine Review8h
The biggest investments 2 orthopedic surgeons will make this year
From investments in robotics to zeroing in on personal well-being, surgeons will make a number of different investments in 2025.
Earnings call transcript: Implantica Q4 2024 sees mixed financial results
Implantica reported a mixed financial performance for Q4 2024, with a 30% year-over-year decrease in quarterly revenue to €442,000, while full-year net sales rose by 38% to €1.9 million. The company's ...
Becker's Dental Review3h
Conflict resolution in the dental office: Tips from a DSO exec
Dr. Lyon, a chief dental officer for the division of orthodontics and pediatric dentistry for Dental Care Alliance, spoke with Becker's about the importance of conflict resolution in the dental office ...
Becker's Dental Review2h
What DSOs can learn from a controversial Super Bowl ad
After a telehealth company's Super Bowl commercial sparked nationwide debate about pharmaceutical safety and advertising, one DSO executive is reflecting on what the controversy means for patient care ...